You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》高盛下調醫渡科技(02158.HK)目標價至50元 評級「買入」
阿思達克 12-15 10:09
高盛發表報告指,醫渡科技(02158.HK)早前舉行了人工智能醫療健康研討會,公司首席執行官宮盈盈等高級管理層出席了研討會。 該行認爲,是次研討會集合了內部和外部持份者的觀點,爲公司在醫療保健領域的人工智能發展方向提供更多色彩,並詳細討論現有和潛在使用個案,包括政府、研究機構/醫院、生命科學公司、保險公司、醫生和患者。 高盛下調醫渡科技股份目標價,由56元降至50元,評級維持「買入」,並調低集團明年至2026年收入預測6%至12%,以反映中期業績表現。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account